Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23years

被引:11
|
作者
Baudu A. [1 ,2 ]
Prétet J.-L. [1 ,2 ,3 ]
Riethmuller D. [1 ,2 ,3 ]
Chotard M. [2 ,3 ]
Mougin C. [1 ,2 ,3 ]
Mercier M. [1 ,2 ,3 ]
机构
[1] Univ Franche-Comte
[2] EA 3181, FED4234
[3] CHU Besancon
关键词
Epidemiology; Genotyping; HPV infection; Screening; Young females;
D O I
10.1016/j.jegh.2013.11.003
中图分类号
学科分类号
摘要
Investigation of the prevalence and risk factors of human papillomavirus (HPV) infection is the basis for developing prophylactic strategies against cervical cancer, especially for young women. This study aimed to assess the prevalence and risk factors of HPV infection among a cohort of sexually active young French women eligible for catch-up vaccination. Between 1997 and 2007, 2163 women aged 15-23. years attending consultations at the department of gynecology in the Hospital of Besançon (France) were screened for high risk HPV (HR HPV) infection. Risk factors were investigated through a questionnaire sent to all participants in 2010. HPV DNA was detected by HC2 and Probe Set assays. The overall prevalence for HR HPV and HPV16, 18 and/or HPV45 was 44.6% (95% CI, 42.5-46.7%) and 19% (95% CI, 17.3-20.7%), respectively. The response rate to the questionnaire was 22.6%. The prevalence of independent risk factors (age older than 19, smoking, and oral contraception) for HPV 16/18/45 infection in this population was less than 20%. Based on this study, HPV vaccination should be offered not only to teenage girls, but also to young women, regardless of their sexual activity. © 2014 Ministry of Health, Saudi Arabia.
引用
收藏
页码:35 / 43
页数:8
相关论文
共 50 条
  • [31] Risk Factors for Cervical Human Papillomavirus Infection and High-Grade Intraepithelial Lesion in Women Aged 20 to 31 Years in Germany
    Remschmidt, Cornelius
    Kaufmann, Andreas M.
    Hagemann, Ingke
    Vartazarova, Elena
    Wichmann, Ole
    Delere, Yvonne
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (03) : 519 - 526
  • [32] Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
    Szarewski, A.
    Poppe, W. A. J.
    Skinner, S. R.
    Wheeler, C. M.
    Paavonen, J.
    Naud, P.
    Salmeron, J.
    Chow, S-N.
    Apter, D.
    Kitchener, H.
    Castellsague, X.
    Teixeira, J. C.
    Hedrick, J.
    Jaisamrarn, U.
    Limson, G.
    Garland, S.
    Romanowski, B.
    Aoki, F. Y.
    Schwarz, T. F.
    Bosch, F. X.
    Harper, D. M.
    Hardt, K.
    Zahaf, T.
    Descamps, D.
    Struyf, F.
    Lehtinen, M.
    Dubin, G.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) : 106 - 116
  • [33] Human Papillomavirus Prevalence, Genotype Diversity, and Risk Factors Among Transgender Women and Nonbinary Participants in the P18 Cohort Study
    LoSchiavo, Caleb
    Greene, Richard E.
    Halkitis, Perry N.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 502 - 505
  • [34] Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma
    Harabajsa, Suzana
    Sdfcic, Hajdi
    Klasic, Marija
    Milavic, Marija
    Lepej, Snjezana Zidovec
    Grgic, Ivana
    Petranovic, Matea Zajc
    Jakopovic, Marko
    Smojver-Jezek, Silvana
    Korac, Petra
    CROATIAN MEDICAL JOURNAL, 2023, 64 (02) : 84 - 92
  • [35] Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of Subsequent Infection in Men
    Lu, Beibei
    Hagensee, Michael E.
    Lee, Ji-Hyun
    Wu, Yougui
    Stockwell, Heather G.
    Nielson, Carrie M.
    Abrahamsen, Martha
    Papenfuss, Mary
    Harris, Robin B.
    Giuliano, Anna R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 511 - 516
  • [36] Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: Preliminary data
    Tiews, Sven
    Steinberg, Winfried
    Schneider, Wladimir
    Hanrath, Christoph
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S11 - S15
  • [37] Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis
    Gupta, S.
    Sodhani, P.
    Sharma, A.
    Sharma, J. K.
    Halder, K.
    Charchra, K. L.
    Sardana, S.
    Singh, V.
    Sehgal, A.
    Das, B. C.
    CYTOPATHOLOGY, 2009, 20 (04) : 249 - 255
  • [38] A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18–26 years
    Cristina Giambi
    Serena Donati
    Francesca Carozzi
    Stefania Salmaso
    Silvia Declich
    Marta L Ciofi degli Atti
    Guglielmo Ronco
    Maria P Alibrandi
    Silvia Brezzi
    Natalina Collina
    Daniela Franchi
    Amedeo Lattanzi
    Maria C Minna
    Roberto Nannini
    Elena Barretta
    Elena Burroni
    Anna Gillio-Tos
    Vincenzo Macallini
    Paola Pierotti
    Antonino Bella
    BMC Infectious Diseases, 13
  • [39] High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years
    Zhang, Guorui
    Lang, Jinghe
    Shen, Keng
    Zhu, Lan
    Xiang, Yang
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (01) : 47 - 52
  • [40] Risk of Autoimmune Diseases (AD) After Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine Immunization in Women Aged 9 to 25 Years in the United Kingdom: An Observational Cohort Study
    Willame, Corinne
    Rosillon, Dominique
    Zima, Julia
    Angelo, Maria-Genalin
    Stuurman, Anke
    Vroling, Hilde
    van Staa, Tjeerd
    Boggon, Rachael
    Bunge, Eveline
    Pladevall-Vila, Manel
    Baril, Laurence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 409 - 409